Medifast, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $89.3M | $90.9M | $94.4M | $87.7M | $104.2M | $163.7M | $77.0M | $81.4M |
| Accounts Receivable | — | — | — | — | — | $584.0K | $1.4M | $1.0M |
| Inventory | $20.2M | $42.4M | $54.6M | $118.9M | $180.0M | $53.4M | $48.8M | $38.9M |
| Total Current Assets | $201.7M | $214.4M | $224.0M | $222.8M | $306.9M | $234.3M | $154.2M | $145.5M |
| Property, Plant & Equipment | $31.2M | $37.5M | $51.5M | $57.2M | $56.1M | $27.6M | $26.0M | $19.7M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $248.0M | $284.2M | $309.9M | $316.2M | $398.3M | $276.1M | $194.7M | $169.4M |
| Liabilities | ||||||||
| Accounts Payable | $15.1M | $23.1M | $39.2M | $53.1M | $70.9M | $36.1M | $22.6M | $19.0M |
| Total Current Liabilities | $43.0M | $64.2M | $92.3M | $140.9M | $169.8M | $111.4M | $79.4M | $60.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $49.1M | $74.1M | $108.4M | $161.2M | $195.9M | $118.8M | $89.8M | $60.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $158.3M | $176.8M | $174.6M | $139.9M | $190.3M | $154.4M | $168.8M | $131.3M |
| Total Stockholders' Equity | $198.9M | $210.1M | $201.5M | $155.0M | $202.5M | $157.2M | $104.8M | $109.1M |